Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
शेयरों में रैंक #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
शेयर मूल्य
$0.00185055
मार्केट कैप
$48.29K
बदलाव (1 दिन)
-3.55%
बदलाव (1 वर्ष)
30.31%
देश
GB
व्यापार Nuformix plc (NFX)

श्रेणी

Nuformix plc (NFX) के लिए P/S अनुपात
September 2026 को P/S अनुपात TTM: 0.00
Nuformix plc की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/S अनुपात (TTM) 0.00 है। 2024 के अंत में, कंपनी का P/S अनुपात 0.00 था।
Nuformix plc के लिए 2014 से 2026 तक P/S अनुपात का इतिहास
हर वर्ष के अंत में P/S अनुपात
वर्ष P/S अनुपात परिवर्तन
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए P/S अनुपात
कंपनी P/S अनुपात P/S अनुपात में अंतर देश
10.44 -
US
26.12 -
US
3.76 -
AU
12.01 -
NL
- -
CH